Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04682977 · ClinicalTrials.gov registry record · NA
Piloting the IPROACTIF Program to Preserve Functioning and Prevent Cognitive Decline
A NA study of Heart Disease (Coronary Artery Disease, Ischemic Heart Disease, Hypertensive Heart Disease) and Uncontrolled Diabetes (HBA1c ≥ 10), sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT04682977: Completed NA study of Heart Disease (Coronary Artery Disease, Ischemic Heart Disease, Hypertensive Heart Disease) and Uncontrolled Diabetes (HBA1c ≥ 10), sponsored by University of Illinois at Chicago.
NCT04682977 is a NA study of Heart Disease (Coronary Artery Disease, Ischemic Heart Disease, Hypertensive Heart Disease) and Uncontrolled Diabetes (HBA1c ≥ 10) that has completed, run by University of Illinois at Chicago. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04682977, a NA study of Heart Disease (Coronary Artery Disease, Ischemic Heart Disease, Hypertensive Heart Disease) and Uncontrolled Diabetes (HBA1c ≥ 10), has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
Conduct a pilot randomized control to assess the preliminary efficacy of IPROACTIF, an occupational therapist-delivered primary care intervention for aging and chronic disease management.
Primary Outcome
Validated self-reported assessment; respondent identifies up to 5 important activities they are experiencing difficulty with. Total score = sum of the activity scores/number of activities. scoring Scores can range from 0 to 10; higher scores indicate better physical functioning Minimal clinically important difference in previous studies = 1.2-2.2 points
Conditions Studied
Interventions
- OTHER IPROACTIF (Integrated PRimary Care and Occupational Therapy for Aging and Chronic Disease Treatment to preserve Independence and Functioning)
- OTHER Usual primary care services
Study Locations (1)
Illinois
- University of Illinois at Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2021-08-11 |
| Est. Completion | 2024-03-01 |
| Phase | NA |
What the finished NCT04682977 record still lists
NCT04682977 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Heart Disease (Coronary Artery Disease, Ischemic Heart Disease, Hypertensive Heart Disease) appearing as the primary indexed condition, and to 2 interventions - of which IPROACTIF (Integrated PRimary Care and Occupational Therapy for Aging and Chronic Disease Treatment to preserve Independence and Functioning) is the first listed.
NCT04682977 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT04682977 about?
NCT04682977 is a clinical study titled "Piloting the IPROACTIF Program to Preserve Functioning and Prevent Cognitive Decline". Conduct a pilot randomized control to assess the preliminary efficacy of IPROACTIF, an occupational therapist-delivered primary care intervention for aging and chronic disease management.
What is the current status of trial NCT04682977?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2021-08-11. Estimated completion is 2024-03-01.
What conditions does trial NCT04682977 study?
This clinical trial studies the following conditions: Heart Disease (Coronary Artery Disease, Ischemic Heart Disease, Hypertensive Heart Disease), Uncontrolled Diabetes (HBA1c ≥ 10).
What interventions are being tested in trial NCT04682977?
The interventions under investigation include: IPROACTIF (Integrated PRimary Care and Occupational Therapy for Aging and Chronic Disease Treatment to preserve Independence and Functioning) (OTHER), Usual primary care services (OTHER).
Who is sponsoring clinical trial NCT04682977?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04682977 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04682977's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI